Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?
Sushanta Halder, Soumi Basu, Shobhit P. Lall, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 4-5, pp. 305-324
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities
Heba A. Elsebaie, Tarek F. El‐Moselhy, Eman A. El-Bastawissy, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107101-107101
Closed Access | Times Cited: 15
Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Exploring binding potential of two new indole alkaloids from Nauclea officinalis against third and fourth generation EGFR: druglikeness, in silico ADMET, docking, DFT, molecular dynamics simulation, and MMGBSA study
Sanket Rathod, Sonali Shinde, Prafulla B. Choudhari, et al.
Natural Product Research (2024), pp. 1-8
Open Access | Times Cited: 9
Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications
Jiatong Li, Ao Gu, Xiao‐Mei Nong, et al.
The Chemical Record (2023) Vol. 23, Iss. 12
Closed Access | Times Cited: 16
Synthesis and biological evaluation of 1-phenyl-tetrahydro-β-carboline-based first dual PRMT5/EGFR inhibitors as potential anticancer agents
Juan Zhang, Xuliang Liu, Na Sa, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116341-116341
Closed Access | Times Cited: 6
Integrating spatial transcriptomics and single-cell RNA-sequencing reveals epithelial cell alterations in benign prostatic hyperplasia following finasteride treatment
Yanting Shen, Xiawei Fei, Li‐Yang Dai, et al.
Genes & Diseases (2025), pp. 101526-101526
Open Access
A supramolecular FRET signal amplification nanoprobe for high contrast and synchronous in situ imaging of cell surface receptor homodimers/heterodimers
Ya Wang, Yao Feng, Lulu Song, et al.
Chemical Science (2025)
Open Access
Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases
Junjie Kuang, Jun Li, Siwei Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Investigating the Anticancer Activity of Novel 1,2,4-Oxadiazole-Linked 1,2,3-Triazole Moieties via EGFR/pI3K/mTOR Cascade Down-Regulation
Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel‐Hamid, et al.
Polycyclic aromatic compounds (2025), pp. 1-20
Closed Access
Imaging Ligand‐Receptor Interactions at Single‐Protein Resolution with DNA‐PAINT
Monique Honsa, Isabelle Baudrexel, L. Heinze, et al.
Small Methods (2025)
Open Access
1,3,4-Oxadiazole Based EGFR Inhibitors as Anticancer Therapeutics: SAR Study and Binding Mode of Interaction Analysis
Ajeya Samanta, Avik Maji, Abhik Paul, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100265-100265
Open Access
Fexofenadine Overcomes Osimertinib Resistance by Inhibiting c‐Met in Non‐Small Cell Lung Cancer
Kenneth K.W. To, Kwong‐Sak Leung, William C. Cho
MedComm – Oncology (2025) Vol. 4, Iss. 2
Open Access
Design, Synthesis, and Biological Evaluation of Newly Synthesized Cinnamide-Fluorinated Containing Compounds as Bioactive Anticancer Agents
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Maha Al‐Ghamdi, et al.
ACS Omega (2024) Vol. 9, Iss. 16, pp. 18505-18515
Open Access | Times Cited: 3
HER3 receptor and its role in the therapeutic management of metastatic breast cancer
Meiying Zhu, Minghui Yu, Yuan Meng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Design, synthesis, and antiproliferative screening of new quinoline derivatives bearing a cis-vinyl triamide motif as apoptosis activators and EGFR-TK inhibitors
Hany M. Abd El‐Lateef, Ahmed Gaafar Ahmed Gaafar, Arwa Sultan Alqahtani, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24781-24790
Open Access | Times Cited: 3
Targeting esophageal carcinoma: molecular mechanisms and clinical studies
Wenjing Wang, Lisha Ye, Huihui Li, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 3
Epithelial–mesenchymal transition to Mitigate Age-Related Progression in Lung Cancer
Riya Thapa, Saurabh Gupta, Gaurav Gupta, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102576-102576
Closed Access | Times Cited: 3
Nano-engineering nanomedicines with customized functions for tumor treatment applications
Yuxin Wang, Shimei Li, Xiangling Ren, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors
Selene Ingusci, Bonnie L. Hall, Justus B. Cohen, et al.
Deleted Journal (2024) Vol. 32, Iss. 1, pp. 200761-200761
Open Access | Times Cited: 2
From Tumor to Bone: Growth Factor Receptors as Key Players in Cancer Metastasis
Khalid S. Mohammad, Shahid Akhtar Akhund
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 2
Synthesis and biological research of new imidazolone-sulphonamide-pyrimidine hybrids as potential EGFR-TK inhibitors and apoptosis-inducing agents
Dalal Nasser Binjawhar, Hanadi A. Katouah, Najla A. Alshaye, et al.
RSC Advances (2024) Vol. 14, Iss. 28, pp. 20120-20129
Open Access | Times Cited: 2
Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK
Hany M. Abd El‐Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23495-23504
Open Access | Times Cited: 2
Investigation of the regulation of EGF signaling by miRNAs, delving into the underlying mechanism and signaling pathways in cancer
Darmadi Darmadi, Zafar Aminov, Ahmed Hjazi, et al.
Experimental Cell Research (2024) Vol. 442, Iss. 2, pp. 114267-114267
Closed Access | Times Cited: 2
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma
Ozlem Sherif, Said Abdullah Khelwatty, Izhar Bagwan, et al.
Oncology Reports (2024) Vol. 52, Iss. 6
Open Access | Times Cited: 2
Clusterin Expression in Colorectal Carcinomas
Teresa Téllez, Desirée Martín‐García, Maximino Redondo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14641-14641
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top